Skip to content
value.today

Alto Neuroscience, Inc.: insider trading

42 trades by 9 directors, officers and 10% owners since 2024, from their SEC Form 4 and 5 filings.

Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$5.6 M
8 sales by 2 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$5.6 M
8 sales

Insider buying and selling by month

Open-market purchases and sales by value, last three years.

$9.9 M-$3.6 M$0Feb 2024: bought $9.9 M (4 trades), sold $0 (0 trades)Feb 24Mar 2024: bought $101 K (2 trades), sold $0 (0 trades)MarJul 2024: bought $191 K (3 trades), sold $0 (0 trades)JulSep 2026: bought $0 (0 trades), sold $3.6 M (3 trades)SepNov 2026: bought $0 (0 trades), sold $2.1 M (5 trades)Nov
Bought (open market)Sold (open market)Hover a month for the totals

Insiders (9)

Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.

Alto Neuroscience, Inc. insiders
InsiderShares owned directlyBought, 12 mSold, 12 mLatest trade
Michael Conick Hanley Jr.CHIEF OPERATING OFFICER0—$2.1 M
Nicholas Conrad SmithPRESIDENT AND CFO79,060—$3.6 M
Amit EtkinPRESIDENT AND CEO, Director833,949——
Adam SavitzCHIEF MEDICAL OFFICER———
Alpha Wave Global, LP10% owner———
Apeiron Investment Group Ltd.See Remarks251,881——
Chen Po Yu (Jeff)Director47,709——
Christopher Nixon CoxDirector———
Gwill YorkDirector23,917——

Trades#

Alto Neuroscience, Inc.: insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Michael Conick Hanley Jr.CHIEF OPERATING OFFICEROption exercise10b5-1 plan+2,896$2.350$7 K2,896Form 4
filed Michael Conick Hanley Jr.CHIEF OPERATING OFFICERSell10b5-1 plan-2,896$26.48$77 K0Form 4
filed Michael Conick Hanley Jr.CHIEF OPERATING OFFICEROption exercise10b5-1 plan+2,104$2.350$5 K2,104Form 4
filed Michael Conick Hanley Jr.CHIEF OPERATING OFFICERSell10b5-1 plan-2,104$26.82$56 K0Form 4
filed Michael Conick Hanley Jr.CHIEF OPERATING OFFICEROption exercise10b5-1 plan+17,729$2.350$42 K17,729Form 4
filed Michael Conick Hanley Jr.CHIEF OPERATING OFFICEROption exercise10b5-1 plan+44,271$2.350$104 K62,000Form 4
filed Michael Conick Hanley Jr.CHIEF OPERATING OFFICEROption exercise10b5-1 plan+8,000$2.350$19 K70,000Form 4
filed Michael Conick Hanley Jr.CHIEF OPERATING OFFICERSell10b5-1 plan-56,410$27.46$1.5 M13,590Form 4
filed Michael Conick Hanley Jr.CHIEF OPERATING OFFICERSell10b5-1 plan-10,895$28.43$310 K2,695Form 4
filed Michael Conick Hanley Jr.CHIEF OPERATING OFFICERSell10b5-1 plan-2,695$29.09$78 K0Form 4
filed Nicholas Conrad SmithPRESIDENT AND CFOOption exercise+55,000$2.320$128 K79,060Form 4
filed Nicholas Conrad SmithPRESIDENT AND CFOOption exercise10b5-1 plan+24,056$2.350$57 K48,116Form 4
filed Nicholas Conrad SmithPRESIDENT AND CFOSell10b5-1 plan-23,170$25.78$597 K24,946Form 4
filed Nicholas Conrad SmithPRESIDENT AND CFOSell10b5-1 plan-886$26.87$24 K24,060Form 4
filed Nicholas Conrad SmithPRESIDENT AND CFOOption exercise10b5-1 plan+56,455$2.350$133 K80,515Form 4
filed Nicholas Conrad SmithPRESIDENT AND CFOOption exercise10b5-1 plan+54,375$2.350$128 K134,890Form 4
filed Nicholas Conrad SmithPRESIDENT AND CFOSell10b5-1 plan-110,830$26.58$2.9 M24,060Form 4
filed Amit EtkinPRESIDENT AND CEO, DirectorGift-400,000——833,949Form 4
filed Amit EtkinPRESIDENT AND CEO, DirectorShares withheld for tax-6,227$19.69$123 K1.23 MForm 4
filed Nicholas Conrad SmithCHIEF FINANCIAL OFFICER & CBOShares withheld for tax-2,806$19.69$55 K24,060Form 4
filed Adam SavitzCHIEF MEDICAL OFFICERBuyindirect+2,931$13.22$39 K39,851Form 4
filed Adam SavitzCHIEF MEDICAL OFFICERBuyindirect+10,681$12.53$134 K35,532Form 4
filed Adam SavitzCHIEF MEDICAL OFFICERBuyindirect+1,388$13.15$18 K36,920Form 4
filed Nicholas Conrad SmithCHIEF FINANCIAL OFFICERBuy+1,600$15.80$25 K22,316Form 4
filed Nicholas Conrad SmithCHIEF FINANCIAL OFFICERBuy+4,550$16.56$75 K26,866Form 4
filed Amit EtkinPRESIDENT AND CEO, DirectorGrant or award+34,711——1.24 MForm 4
filed Nicholas Conrad SmithCHIEF FINANCIAL OFFICERGrant or award+19,153——20,716Form 4
filed Apeiron Investment Group Ltd.See RemarksConversion+251,881——251,881Form 4
filed Apeiron Investment Group Ltd.See RemarksConversionindirect+674,658——674,658Form 4
filed Alpha Wave Global, LP10% ownerConversionindirect+1.96 M——1.96 MForm 4
filed Alpha Wave Global, LP10% ownerConversionindirect+1.14 M——3.11 MForm 4
filed Alpha Wave Global, LP10% ownerBuyindirect+600,000$16.00$9.6 M3.71 MForm 4
filed Nicholas Conrad SmithCHIEF FINANCIAL OFFICERBuy+1,563$16.00$25 K1,563Form 4
filed Amit EtkinPRESIDENT AND CEO, DirectorConversion+11,777——1.20 MForm 4
filed Chen Po Yu (Jeff)DirectorConversion+39,259——39,259Form 4
filed Gwill YorkDirectorConversion+23,917——23,917Form 4
filed Adam SavitzCHIEF MEDICAL OFFICERConversionindirect+7,851——7,851Form 4
filed Christopher Nixon CoxDirectorConversionindirect+588,898——588,898Form 4
filed Amit EtkinPRESIDENT AND CEO, DirectorBuy+3,125$16.00$50 K1.21 MForm 4
filed Christopher Nixon CoxDirectorConversionindirect+126,755——715,653Form 4
filed Chen Po Yu (Jeff)DirectorConversion+8,450——47,709Form 4
filed Adam SavitzCHIEF MEDICAL OFFICERBuyindirect+17,000$16.00$272 K24,851Form 4

Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice